A study published in the journal Cancer found significant rate increases in the use of various modalities to treat male breast cancer between 2004 and 2014 and better overall survival rates among men who received radiotherapy, chemotherapy and endocrine therapy. Researchers used a cohort of 10,873 men with stage I to stage III breast cancer, median age of 64, and found that 70% of those who underwent breast conservation received radiotherapy, while approximately 44% received chemotherapy and 62% of those with estrogen receptor-positive disease received endocrine therapy.
Research examines trends in male breast cancer treatment
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.